Publications
5674 Results
- Journal / Conference
- Society for Medical Decision Making (October 13-17, 2018, Montreal, Quebec, CAN ), poster
- Year
- 2018
- Research Committee(s)
- Breast and Gastrointestinal
- Study Number(s)
- S1513
Influence of Real-World Structural Assumptions on Value of Information (VOI) Analysis
- Journal / Conference
- IASCL (WCLC) (September 23-26, 2018, Toronto, CAN), abst.#P1.16-47, IASLC Book of Abstracts p. 421
- Year
- 2018
- Research Committee(s)
- Lung
- Study Number(s)
- CTSU/A151216
Adjuvant targeted therapy following standard adjuvant therapy for resected NSCLC: An initial report from ALCHEMIST (A151216)
- Journal / Conference
- Blood 2018 132:33(suppl 1), abst 33; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), oral, abst. 33
- Year
- 2018
- Research Committee(s)
- Leukemia
- Study Number(s)
- S1318
Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with Newly Diagnosed Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia
- Journal / Conference
- Breast Cancer Research, Nov 28;20:146
- Year
- 2018
- Research Committee(s)
- Breast
- PMID
- PMID30486865
- PMC
- PMC6264595
- Study Number(s)
- S0221
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
- Journal / Conference
- Journal of Urology Vol. 199, No. 4S, Supplement, LBA26, p. e1166; American Urological Association Annual Meeting 2018
- Year
- 2018
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CTSU/EA8141
Phase II trial of neoadjuvant chemotherapy followed by extirpative surgery for patients with high grade upper tract urothelial carcinoma (HG UTUC): results from ECOG-ACRIN 8141
- Journal / Conference
- JCO Clinical Cancer Informatics Dec;2:1-8; DOI: 10.1200/CCI.17.00122; online 2/2/18
- Year
- 2018
- Research Committee(s)
- Cancer Care Delivery and Multiple sites
- PMID
- PMID30652537
- PMC
- PMC6668704
Incorporating digital tools to improve clinical trial infrastructure: A white paper from the digital engagement committee of SWOG [Special Article]
- Journal / Conference
- Blood 132:6; doi: https://doi.org/10.1182/blood-2018-99-116653; American Society of Hematology Annual Meeting (Dec 1-4, 2018, San Diego, CA), oral/plenary
- Year
- 2018
- Research Committee(s)
- Leukemia
- Study Number(s)
- CTSU/A041202
Ibrutinib alone or in combination with rituximab produces superior progression free survival compared with bendamustine plus rituximab in untreated older patients with chronic lymphocytic leukemia: Results of Alliance North American Intergroup Study A041202
- Journal / Conference
- European Urology Focus Jul;4(4):522-524
- Year
- 2018
- Research Committee(s)
- Genitourinary
- PMID
- PMID30197040
- Study Number(s)
- S1602
Background and update for S1602 “A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-Naïve High-Grade Non-Muscle Invasive Bladder Cancer”
- Journal / Conference
- Lancet Haematology Dec;5(12):e609-e617
- Year
- 2018
- Research Committee(s)
- Lymphoma
- PMID
- PMID30501868
- PMC
- PMC6342507
- Study Number(s)
- CTSU/9177
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study
- Journal / Conference
- Journal of Urology Vol. 199, No. 4S, Supplement, abst PD66-01; American Urological Association Annual Meeting (May 18-21, 2018, San Francisco, CA),
- Year
- 2018
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0337